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Intravenous leiomyomatosis: Two cases with
different routes of tumor extension
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Intravenous leiomyomatosis is a rare smooth muscle tumor. We report two cases of intravenous leiomyomatosis that grew
along different routes of the venous system into the inferior vena cava and the right atrium. The different route of
extension makes a difference in the ease of excision of tumor masses. Using MEDLINE together with the references in
each publication, we identified all cases of intracardiac leiomyomatosis reported in the English literature in the period
between 1980 and 2003 and performed a brief review on this potentially lethal disease entity. (J Vasc Surg 2004;39:
465-9.)
Intravenous leiomyomatosis (IVL) is a rare neoplasm
characterized by a histologically benign-looking smooth
muscle cell tumor mass growing within the uterine and
extrauterine venous system.1 Although it is nonmalignant,
IVL may grow into the venous system and extend along the
inferior vena cava (IVC), reaching the right-sided cardiac
chambers and eventually the pulmonary artery and result-
ing in death. In addition, the differentiation between the
benign IVL and the malignant leiomyosarcoma can be
difficult. However, long-term survival up to 12 years has
been reported after the successful removal of tumor masses
of IVL.2,3 We report two cases of IVL that grew along
different venous routes.
CASE REPORT
Case 1. A 41-year-old nulliparous Chinese woman presented
with an incidental finding of a large pelvic mass during the routine
body check-up. Computerized tomography (CT) of the abdomen
and pelvis revealed a heterogenous uterine mass that measured 17
cm in size and encroached on the confluence of right common iliac
vein. There was also a tumor mass within the IVC up to the right
atrium. Echocardiography showed a free-floating echogenic mass
in the right atrium. With these findings, a diagnosis of IVL of the
uterus with intracaval and cardiac extension via the right common
iliac vein was made. The patient was scheduled for a two-stage
operation.
A median sternotomy was made. Cardiopulmonary bypass was
instituted between the ascending aorta, the superior vena cava, and
the right femoral vein. The heart was arrested by cold blood
cardioplegia, and the total circulatory arrest started when the
patient’s rectal temperature was lowered to 18°C. During the
11-minute circulatory arrest, right atriotomy was performed and
the tumor was extracted from the right atrium and the IVC down
to the infrarenal level (Fig 1). The circulation was restarted after
the atrial wall had been closed, and the patient was rewarmed. The
cardiopulmonary bypass was disconnected, and the rest of the
operation was uneventful. The postoperative recovery was uncom-
plicated.
Six weeks later, a second-stage operation via laparotomy was
performed. A large, convoluted tumor mass was seen arising from
the uterus. Total hysterectomy and bilateral salpingo-oophorec-
tomy (THBSO) was performed. It was observed intraoperatively
that the tumor growth extended into the right uterine vein,
growing along the right internal iliac vein and the right common
iliac vein and finally reaching the IVC. The right internal iliac vein
and all its branches were exposed after the meticulous dissection,
and the tumor thrombi inside were freed to the right common iliac
vein. The right colon and small bowel were reflected to control the
IVC at the level of renal veins. The right external and internal iliac
veins and left common iliac vein were also controlled with vascular
clamps. Then, venotomy was made on the right common iliac vein
to remove the tumor mass in the IVC completely. The excised
lobulated, grey-white rubbery tumor mass measured as 75 cm in
length, with varying width (Fig 2).
Histologic examination of the uterus and intravascular tumor
mass confirmed the diagnosis of IVL. Immunohistochemical stud-
ies showed that the tumor cells were diffusely and strongly positive
on the smooth muscle markers, including desmin and smooth
muscle actin, confirming their smooth muscle nature. Although
many of the tumor cells showed bizarre nuclear morphology with
hyperchromatic multilobated nuclei, the mitotic activity was low,
with mitotic index of less than 1 per 50 high-power fields (Fig 3).
Case 2. A 47-year-old multiparous Chinese woman pre-
sented with a 3-month history of abdominal distension. On exam-
ination, a large abdominal mass was found. CT of the abdomen
and pelvis showed a huge heterogenous abdominal mass extending
from the subhepatic region down to the pelvis. There was also a
tumor mass within the left ovarian vein, the left renal vein, and the
IVC extending into the right atrium. Echocardiography showed a
free-floating mass in the right atrium. Ultrasound-guided biopsy of
the abdominal mass revealed fascicles of smooth muscle cells
without nuclear atypia. A diagnosis of IVL of the uterus with
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intracaval and cardiac extension via the left ovarian vein was made.
She was operated on with the two-stage approach to excise the
tumor masses.
At the first-stage operation, using cardiopulmonary bypass,
the right atriotomy was performed and extended down to the IVC.
The tumor was dissected from the surrounding adhesions down to
the infrarenal level. Under direct vision, the tumor divided at the
infrarenal level and was removed without tension. The procedure
was uneventful and the total circulatory arrest time was 27 minutes.
The postoperative recovery was uncomplicated. Six weeks later, the
second-stage operation was performed via laparotomy. A large
uterine tumor was found occupying the entire abdominal cavity. It
extended along the left ovarian vein into the left renal vein and then
reached the IVC. THBSO was performed. Then, the right colon
Fig 1. Tumor mass removed from the right atrium.
Fig 2. 75-cm-long grey-white rubbery tumor mass removed from inferior vena cava.
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and small bowel were reflected and full Kocherization of duode-
num was performed. Vascular control was achieved with vascular
clamps at the bilateral renal veins as well as the IVC between the
level of the right adrenal vein and the origin of the right ovarian
vein. Venotomy was then performed on the left renal vein, and the
caval tumor mass was removed en bloc with the left ovarian vein
and the uterine tumor. The operation was uncomplicated, and the
tumor masses were completely excised. Histologic examination of
the uterus and intravascular tumor masses confirmed the diagnosis
of IVL. There was no nuclear atypia, and the mitotic index was low.
DISCUSSION
IVL is a rare smooth muscle cell tumor that grows
within venous channels but does not invade. There have
been about 200 cases reported in the English-language
literature so far. The extension of the tumor is mostly
through the uterine veins, and the tumor can progress
along the veins into the IVC. Further extension into the
right-sided cardiac chambers will lead to intracardiac
leiomyomatosis (ICL). We identified all cases of ICL re-
ported in the English-language literature, using MED-
LINE together with the references in each publication. A
total of 68 cases of ICL, including our cases, reported
between 1980 and 2003 were reviewed (Table).
Almost 60% of cases in our review were reported in the
last 10 years, including these two cases and another case
previously reported by our unit.4 This may be because
diagnosis was readily made with increasing knowledge of
the disease entity. However, it is believed that the number
of IVL is still underestimated because the diagnosis was
easily missed, particularly in early stage, when tumor exten-
sion remained inside the small vessels of myometrium and
could not be detected even with preoperative imaging.
Correct diagnosis relies on a high index of suspicion. IVL
should be suspected when extrauterine tumor is observed
in the form of wormlike or nodular plugs within pelvic veins
during operation by the surgeons or unexpectedly after
microscopic examination of a hysterectomy specimen by
the pathologists. In addition, if there is clinical evidence of
deep vein thrombosis, preoperative imaging of pelvic veins
should be considered.
Table I. Summary of 68 cases of intracardiac
leiomyomatosis reported between 1900 and 2003.
Total number of cases 68
Median age in years (range) 47 (26-76)
Median time interval between hysterectomy and
diagnosis of ICL in years (range)
4 (0.25-47)
History of hysterectomy 38 (55.9%)
Presenting symptoms
Congestive heart failure 45 (66.1%)
Venous obstruction 4 (5.9%)
Abdominal distension 10 (14.7%)
Sudden death 1 (1.5%)
Others 8 (11.8%)
Extent of involvement
Right atrium 31 (45.6%)
Right ventricle 31 (45.6%)
Pulmonary vessel 6 (8.8%)
Route of extension
Unknown 14 (20.6%)
Unilateral 50 (73.5%)
Bilateral 4 (5.9%)
Iliac only 32 (47.1%)
Ovarian only 17 (25.0%)
Both iliac and ovarian 5 (7.3%)
Treatment
None 3 (4.4%)
Incomplete excision 17 (25.0%)
Complete excision with one-stage operation 19 (27.9%)
Complete excision with two-stage operation 29 (42.7%)
Fig 3. Microscopic picture of tumor cells with bizarre nuclear morphology and hyperchromatic multilobated nu-
clei.
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Thirty-eight (55.9%) of the 68 reported cases of ICL
had a history of hysterectomy. We presumed in those cases
in which the diagnosis of IVL had been missed in the early
stage that the tumor left in the pelvic veins at the time of the
hysterectomy extended up the major vessels toward the
cardiac chambers and presented as ICL in later life. A
median time interval between hysterectomy to the diagno-
sis of ICL was 4 years and could be as long as 47 years.2
Only two-thirds of patients with ICL presented with con-
gestive heart failure, and the tumors of more than 50% of
patients extended to the right ventricle or even to the
pulmonary vessels before they presented. The substantial
time intervals illustrate the silent and slow-growing charac-
teristic of benign smooth muscle tumor. The cardiovascular
function will only decompensate when significant venous
obstruction or tricuspid valve impairment exists.
The cardinal microscopic feature of IVL is intravenous
growths of smooth muscle tumor in the absence of, or
beyond the limits of, uterine leiomyoma. Different sub-
types of IVL, namely, cellular, myxoid and bizarre, have
been described, but most cases are cytologically bland, with
no or minimal nuclear atypia and low mitotic index, as in
Case 2. However, the differentiation between benign and
malignant smooth muscle tumor can be difficult. Although
preoperative imaging by ultrasound scan, CT scan, mag-
netic resonance imaging, or venography helps to delineate
the extent of the tumor,5 it is inadequate to make the
differentiation between benign and malignant lesion.6 If a
two-stage procedure is performed, the histology of the
tumor removed in the first operation may provide some
information on the tumor behavior. However, the histo-
logic appearance of the tumor may vary from place to place,
as shown in our previously reported case of IVL, in which
increased mitotic activity was observed only in the tumor
growths within myometrial vessels.7 It is also the probable
reason why preoperative biopsy is not very useful.6 Above
all, bizarre nuclear morphology, moderate or marked nu-
clear atypia, and a mitotic index of up to 10 per 10 high-
power fields have been rarely reported in IVL,7 as in Case 1.
The differences in cytologic features do not correlate with a
different clinical behavior.8 However, because of the scar-
city of these cases, the implication of these atypical cellular
features remains unclear.
In our review, only about 80% of the reported cases had
a detailed description of the tumor course. The majority of
these cases involved the venous system on one side, and the
uterine vein was more commonly involved than the ovarian
veins. Our cases demonstrated the tumor extension
through two different routes of venous channels (Fig 4). In
Case 1, the tumor extended into the uterine vein, internal
iliac vein, common iliac vein, and then IVC, whereas in
Case 2, the tumor extended into the ovarian vein, renal
vein, and then IVC. The different route of extension might
have an effect on the level of difficulty during surgical
removal. Vascular control before venotomy is more difficult
in the pelvic veins when compared with the renal vein, as
Fig 4. Schematic diagrams illustrating the course of tumor extension with arrows showing the proximal and distal
vascular control in the second-stage operation in each case. (Rt.A.: right atrium; I.V.C.: inferior vena cava; Rt.C.I.V.:
right common iliac vein; Rt.I.I.V.: right internal iliac vein; Lt.R.V.: left renal vein; Lt.O.V.: left ovarian vein)
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illustrated in Case 1 and Case 2, respectively. Precise delin-
eation of tumor course is essential for proper preoperative
planning to ensure the success of complete tumor excision.
Various imaging studies including CT scan, CT angiogra-
phy, or magnetic resonance venography have been used to
delineate the origin, route, and extent of the tumor. To the
best of our knowledge, the 75-cm-long intravascular tumor
mass excised in Case 1 is the longest one reported in the
literature.
Surgery is the treatment of choice, and complete re-
moval of the tumor is mandatory. Incomplete resection of
the tumor may result in recurrences up to 15 years after the
primary occurrence.9 Bilateral oophorectomy is also advis-
able because the tumor is estrogen dependent.10 The treat-
ment choices are single or staged procedures. The latter
approach involves resection of the abdominopelvic and
intrathoracic components in two separate operations within
a short time interval. In our review, 48 (70.6%) patients
successfully achieved a complete excision of tumor. Among
them, 19 (39.6%) patients were operated on with single
procedure, whereas the rest (60.4%) adopted the two-stage
approach.
We adopted two-stage approach in both of our cases
because the single-stage surgery requires a long operative
time and carries increased risk of bleeding because of sys-
temic heparinization required for cardiopulmonary by-
pass.11 In addition, frequent IVC wall attachment pre-
cludes tumor extraction through the right atrium, which
can cause fatal retroperitoneal hemorrhage,12,13 and resec-
tion of the tumor that generally hugs the cardiac cavities
through a single abdominal approach would be dangerous.
In contrast, an initial thoracic approach should allow safe
resection of the intracardiac tumor mass, followed by a
second operation to remove the caval mass and pelvic
tumor. Moreover, adequate proximal vascular control dur-
ing the removal of the pelvic tumor reduces the risk of
tumor dislodgement and fatal pulmonary embolism.14 The
slow growth of the tumor allows for a safe interval between
two major surgical procedures. In the thoracic approach,
we should aim for the tumor clearance below the level of
renal veins to facilitate easier vascular control in the second-
stage laparotomy because higher vascular control requires
mobilization of liver via a right thoracoabdominal incision,
with its associated morbidities. In addition, clamping of the
cava above the hepatic vein confluence will significantly
reduce the preload, necessitating the axillofemoral venous
bypass.
In summary, IVL is a smooth muscle cell tumor that
may grow within veins along various routes. Accurate pre-
operative delineation of tumor extension is essential for the
success of the complete tumor excision. The cure of this
complex disease emphasizes the need for a planned sys-
temic approach by a multidisciplinary surgical team.
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